Latest 8-K filings

Quantum X, Inc., formerly Two Hands Corporation, announced the effectiveness of its name and trading symbol change to QUTX.

Hyperliquid Strategies Inc. has amended its ChEF Purchase Agreement with Chardan Capital Markets LLC, adjusting the pricing for future share sales.

SmartKem, Inc. has successfully regained compliance with Nasdaq's minimum bid price requirement, as confirmed by the exchange.

Future Vision II Acquisition Corp. has secured a one-month extension for its business combination deadline and clarified the non-convertible nature of its rights for short-selling purposes.

Bitmine Immersion Technologies announces a substantial increase in its Ethereum holdings, reaching 5.96 million tokens, and a total crypto and cash portfolio valued at $15.8 billion.

ClearSign Technologies Corporation has released an investor presentation on September 14, 2026, intended for upcoming investor engagements.

Updated overall survival data from Akeso's Phase III HARMONi-2 trial for ivonescimab in advanced NSCLC shows a statistically significant benefit compared to pembrolizumab.

Bowman Consulting Group announced the expiration of its go-shop period for the previously announced merger with Bernhard Capital Partners, with no alternative proposals received.

Cambium Networks Corporation reports the administration of its UK subsidiary, Cambium Networks Ltd., and a substantial 53.6% global workforce reduction.

DeFi Development Corp. announced a 2% increase in its SOL treasury to approximately 2.39 million SOL and established a $300 million at-the-market offering for its preferred stock to fund further SOL accumulation.

Eos Energy Enterprises announced it received an $87 million advance from the U.S. Department of Energy, supporting its second production line and manufacturing capacity expansion.

PennyMac Financial Services provides a Q3 2026 business update, projecting higher pretax income for the Servicing Segment and stable revenue margins in the Production Segment, despite rising interest rates.

Rimini Street, Inc. announced the reinstatement of Steven Hershkowitz as Executive Vice President and Chief Revenue Officer, effective September 14, 2026.

Bionano Genomics highlighted advancements in Optical Genome Mapping (OGM) adoption, reimbursement milestones, and future growth projections at the H.C. Wainwright conference.

Graco Inc. announced the appointment of Richard B. Lewis to its Board of Directors, effective December 3, 2026, strengthening its governance with his extensive operational and commercial experience.

Enbridge Inc. successfully completed a public offering of common shares, raising approximately $3 billion.

NETSTREIT Corp. released an investor presentation on September 14, 2026, showcasing a high-quality, diversified net lease retail portfolio with 100% occupancy, strong tenant credit profiles, and a well-capitalized balance sheet.

Nomadar Corp. has signed a definitive agreement to acquire a majority interest in Fox Soccer Academy, enhancing its international youth soccer development platform.

RF Industries announced record net sales of $23.96 million for its third fiscal quarter of 2026, a 21% year-over-year increase, alongside a substantial surge in net income and improved gross profit margins.

Essential Properties Realty Trust, Inc. released an investor presentation detailing a robust operating update, a strong balance sheet with excellent liquidity, and consistent external growth.

Medicus Pharma Ltd. has mutually agreed with YA II PN, LTD. (Yorkville) to terminate their Standby Equity Purchase Agreement, effective September 11, 2026, with no outstanding borrowings or fees.

Definium Therapeutics reports positive topline data from its Phase 3 Panorama study of DT120 ODT for generalized anxiety disorder, meeting primary and key secondary endpoints.

Thryv Holdings Inc. announced a definitive agreement to sell its print directories business for $142 million in cash, a move aimed at reducing debt and strengthening its balance sheet to focus on its AI-powered SaaS platform.

Cabaletta Bio announced the full exercise of its common stock warrants issued in June 2025, generating substantial gross proceeds.

Piedmont Realty Trust provides updates on property acquisitions and dispositions, and announces a proposed $200 million offering of exchangeable senior notes.

Scholar Rock announces FDA approval of ISEMBYLD (apitegromab-mstn), the first and only muscle-targeted treatment for spinal muscular atrophy (SMA) in adults and children aged 2 and older.

Sphere 3D Corp., operating as DarkHorse Technologies, unveils a strategic shift to leverage its existing 50 MW energized power infrastructure for AI/HPC services, aiming to capitalize on market demand while mitigating interconnection delays.

Telomir Pharmaceuticals announces new research findings from The Ohio State University demonstrating Telomir-Zn's effectiveness in inhibiting cell growth in human and canine osteosarcoma models, supporting parallel development pathways.

Strategy Inc. reported on its Bitcoin holdings and share repurchase activities, noting significant Bitcoin reserves and continued buybacks of preferred stock.

NRx Pharmaceuticals has shared an investor presentation used in recent meetings, indicating ongoing engagement with the financial community.